Posted on December 21, 2010 by Sitemaster
Among prostate cancer specialists, there has been a broad acceptance — for some time — of the idea that a localized prostate cancer “index” tumor with a Gleason score of 6 or less and a volume of ≤ 0.5 cm3 could be considered to be clinically insignificant and therefore did not (necessarily) need to be treated. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: clinical insignificance, clinical significance, Gleason grade, Management, staging, tumor volume | Leave a comment »
Posted on December 6, 2009 by Sitemaster
In today’s news reports we comment on:
- The possible link between obesity and prostate cancer risk
- The economic impact of widespread prostate cancer screening in Europe
- The potential roles of tumor volume and PSMs in projecting need for adjuvant radiotherapy post-surgery
- Biochemical progression after treatment with degarelix (at up to 1 year) … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: adiponectin, adjuvant radiation, biochemical failure, cost, Degarelix, obesity, positive surgical margin, risk, tumor volume | Leave a comment »
